EPISODE · Nov 17, 2025 · 51 MIN
Beyond the Result Ep 5: Data-Driven Stewardship for Cost Savings & Strengthening Financial Health
from Beyond The Result · host Angelo Rago
In this episode of Diasorin’s Beyond the Result podcast,host Angelo Rago speaks with Kyle Rodino, assistant director of the clinicalmicrobiology laboratory at the Hospital of the University of Pennsylvania,about the implementation of a diagnostic stewardship program.Highlights include: · Diagnostic stewardship offers benefits acrossthe board, from accelerating time to results for lab tests, improving patient care, reducing waste in labs and hospitals, increasing efficiency, and more.· It’s a team sport: diagnostic stewardship can’tbe achieved by the laboratory alone. For optimal outcomes, buy-in from other departments, and practical utility is not enough, it must include perspectives from hospital administration, patient-facing clinical care teams, and laboratory management. Conversations should begin with “what’s best for the patient?” rather than “how do we reduce costs?”· Data frameworks used in labs today weredeveloped in an era that didn’t anticipate the need for deep integration and sophisticated analysis. Data from clinical labs can be inherently messy — many tests don’t simply give a binary positive/negative result — and the situationis made worse as hospital systems grow and absorb facilities using a variety of different data platforms. Overcoming these obstacles will be important for enabling more data-centric approaches in the future.· Looking ahead, there is great opportunity tomake diagnostic stewardship more nuanced and tailored. For example, patients might not need every target in a syndromic panel; there are many cases where asubset of those targets is more appropriate. Credits: Host – Angelo Rago, President of Luminex division ofDiasorin Guest – Kyle Rodino, Director of Rittenhouse MolecularLab and Assistant Director of Clinical Microbiology Lab at the University ofPennsylvania HospitalProducers – Stephanie Ibbotson, Sr. Director of StrategicMarketing and Market Access and Michelle Tabb, PhD, Chief Scientific Officer Editor – Britta Good, Graphic Designer, Global Marketing Sign up to be notified for new episodes:https://us.diasorin.com/en/molecular-diagnostics?utm_source=YouTube&utm_medium=YT-description&utm_campaign=Podcast&utm_id=Corporate&utm_term=Ep5
What this episode covers
In this episode of Diasorin’s Beyond the Result podcast,host Angelo Rago speaks with Kyle Rodino, assistant director of the clinicalmicrobiology laboratory at the Hospital of the University of Pennsylvania,about the implementation of a diagnostic stewardship program.Highlights include: · Diagnostic stewardship offers benefits acrossthe board, from accelerating time to results for lab tests, improving patient care, reducing waste in labs and hospitals, increasing efficiency, and more.· It’s a team sport: diagnostic stewardship can’tbe achieved by the laboratory alone. For optimal outcomes, buy-in from other departments, and practical utility is not enough, it must include perspectives from hospital administration, patient-facing clinical care teams, and laboratory management. Conversations should begin with “what’s best for the patient?” rather than “how do we reduce costs?”· Data frameworks used in labs today weredeveloped in an era that didn’t anticipate the need for deep integration and sophisticated analysis. Data from clinical labs can be inherently messy — many tests don’t simply give a binary positive/negative result — and the situationis made worse as hospital systems grow and absorb facilities using a variety of different data platforms. Overcoming these obstacles will be important for enabling more data-centric approaches in the future.· Looking ahead, there is great opportunity tomake diagnostic stewardship more nuanced and tailored. For example, patients might not need every target in a syndromic panel; there are many cases where asubset of those targets is more appropriate. Credits: Host – Angelo Rago, President of Luminex division ofDiasorin Guest – Kyle Rodino, Director of Rittenhouse MolecularLab and Assistant Director of Clinical Microbiology Lab at the University ofPennsylvania HospitalProducers – Stephanie Ibbotson, Sr. Director of StrategicMarketing and Market Access and Michelle Tabb, PhD, Chief Scientific Officer Editor – Britta Good, Graphic Designer, Global Marketing Sign up to be notified for new episodes:https://us.diasorin.com/en/molecular-diagnostics?utm_source=YouTube&utm_medium=YT-description&utm_campaign=Podcast&utm_id=Corporate&utm_term=Ep5
NOW PLAYING
Beyond the Result Ep 5: Data-Driven Stewardship for Cost Savings & Strengthening Financial Health
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m